When is the next results date for P&G Hygiene?

No Upcoming Board Meetings

Has P&G Hygiene declared dividend?

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1100% (₹110 per share), with an ex-date of February 20, 2025. Despite this significant dividend, total returns over recent periods have been negative, with a total return of -14.07% over the last 6 months.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1100%<BR>- Amount per share: 110 per share<BR>- Ex-date: 20 Feb 25<BR><BR>Dividend Yield: 1.52%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -14.76%, the dividend return was 0.69%, resulting in a total return of -14.07%.<BR><BR>Over the past year, the price return was -18.54%, the dividend return was 1.21%, leading to a total return of -17.33%.<BR><BR>In the 2-year period, the price return was -1.98%, the dividend return was 2.66%, which resulted in a total return of 0.68%.<BR><BR>For the 3-year period, the price return was -3.99%, the dividend return was 3.87%, culminating in a total return of -0.12%.<BR><BR>In the 4-year period, the price return was 4.99%, the dividend return was 5.08%, yielding a total return of 10.07%.<BR><BR>Finally, over the last 5 years, the price return was 34.16%, the dividend return was 10.06%, resulting in a total return of 44.22%.<BR><BR>Overall, while Procter & Gamble Hygiene has declared a significant dividend, the total returns over various periods show a mixed performance, with recent periods reflecting negative price returns despite some positive contributions from dividends.

Who are the peers of the P&G Hygiene?

P&G Hygiene's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. P&G Hygiene has the lowest 1-year return at -16.17%, while Gillette India leads with 32.82%.

Peers: The peers of P&G Hygiene are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Hind. Unilever, Godrej Consumer, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. Below Average growth is noted for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Gillette India, Emami, and the rest, while Good growth is seen at Hatsun Agro and Average growth at Bikaji Foods.<BR><BR>Return Snapshot: Gillette India has the highest 1-year return at 32.82%, while P&G Hygiene has the lowest at -16.17%. P&G Hygiene's return is significantly lower than all peers. Additionally, the six-month return is negative for P&G Hygiene, Hind. Unilever, ITC, Godrej Consumer, Emami, and Hatsun Agro.

Who are in the management team of P&G Hygiene?

As of June 2022, the management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, with roles ranging from directors to managing director and chairman.

As of June 2022, the management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>Each member holds a significant role within the company, contributing to its governance and strategic direction.

What does P&G Hygiene do?

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors. As of March 2025, it reported net sales of ₹9,891 Cr and a net profit of ₹1,561 Cr, with a market cap of ₹42,929 Cr.

Overview: <BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling branded packaged fast moving consumer goods in the femcare and healthcare businesses, operating within the FMCG industry and classified as a large-cap company.<BR><BR>History: <BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported are for March 2025, showcasing the company's financial performance.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 9,891 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1,561 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 42,929 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 60.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 1.55% <BR>Debt Equity: -0.83 <BR>Return on Equity: 75.88% <BR>Price to Book: 45.27<BR><BR>Contact Details: <BR>Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099 <BR>Tel: 91-22-28266000 <BR>Email: investorpghh.i@pg.com <BR>Website: http://www.in.pg.com

Who are the top shareholders of the P&G Hygiene?

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

How big is P&G Hygiene?

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, with recent net sales of 4,295.54 Cr and a net profit of 717.65 Cr. Shareholder's funds are 774.86 Cr, and total assets amount to 1,783.69 Cr.

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 4,295.54 Cr and a Net Profit of 717.65 Cr.<BR><BR>For the latest annual period ending June 2024, Shareholder's Funds amounted to 774.86 Cr, while Total Assets were reported at 1,783.69 Cr.

Is P&G Hygiene technically bullish or bearish?

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

How has been the historical performance of P&G Hygiene?

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

Are P&G Hygiene latest results good or bad?

P&G Hygiene's latest results show mixed performance, with a 9.27% QoQ increase in net profit but a 0.95% YoY decline, alongside significant QoQ revenue growth of 22.85% and a modest YoY increase of 1.42%. However, declining operating and PAT margins indicate rising costs and competitive pressures, suggesting challenges ahead.

P&G Hygiene's latest results present a mixed picture. On one hand, the company reported a net profit of ₹209.86 crores for Q2 FY26, which is a 9.27% increase quarter-on-quarter (QoQ) and a slight decrease of 0.95% year-on-year (YoY). This indicates some positive momentum in the short term, but the year-on-year decline raises concerns about sustained profitability.<BR><BR>Revenue for the same quarter reached ₹1,148.85 crores, showing a significant QoQ growth of 22.85% and a modest YoY increase of 1.42%. While the sequential growth is impressive, the year-on-year figure suggests that demand may be stagnating, reflecting challenges in the market.<BR><BR>However, the operating margin has compressed, falling from 28.46% in the previous quarter to 24.79%, and the PAT margin also decreased from 20.54% to 18.27%. This margin compression indicates rising costs and competitive pressures, which could impact future profitability.<BR><BR>Overall, while there are some positive aspects, such as the QoQ growth in revenue and profit, the year-on-year stagnation in revenue growth and declining margins suggest that P&G Hygiene is facing significant challenges in maintaining its performance in a competitive environment. Therefore, the results can be viewed as concerning rather than entirely positive.

Should I buy, sell or hold P&G Hygiene?

Which are the latest news on P&G Hygiene?

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 28-Dec, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 12,965.00, down -0.6%. This is due to consistent underperformance against benchmarks, modest growth rates, high valuation concerns, and reduced investor interest.

As of 28-Dec, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 12,965.00, which reflects a change of -77.65 (-0.6%). This downward movement can be attributed to several factors highlighted in the source data. <BR><BR>Firstly, the stock has shown consistent underperformance against the benchmark, with a year-to-date decline of -11.92% compared to the Sensex's gain of +8.83%. Over the past year, the stock has generated a return of -12.43%, indicating a trend of poor performance relative to broader market indices. Additionally, the stock has underperformed the BSE500 in each of the last three annual periods, further emphasizing its struggles in the market.<BR><BR>Moreover, the company's financial metrics reveal concerns regarding long-term growth. The net sales growth rate over the last five years stands at a modest 6.49%, while operating profit has grown at 8.96%. These figures suggest that the company is not achieving significant growth, which could deter investors. The debtors turnover ratio is also at its lowest, indicating potential issues with receivables management.<BR><BR>Despite having a high return on equity (ROE) of 81.87% and a low debt-to-equity ratio, the stock is considered very expensive with a price-to-book value of 45.2, which may lead investors to view it as overvalued. The stock's performance today has underperformed its sector by -0.98%, and there has been a notable decline in investor participation, with delivery volume falling by -19.52% against the five-day average.<BR><BR>In summary, the combination of consistent underperformance against benchmarks, lackluster growth metrics, high valuation concerns, and declining investor interest are contributing to the falling stock price of Procter & Gamble Hygiene & Health Care Ltd.